+1 to Dr.RaviCardio. Especially the point about "endo perspective but I think this oversi..." — I have seen the same in my own experience with Ireland HSE coverage for.
Want to share my personal experience related to Ireland HSE coverage for since I think it might help others in a similar situation.
I started my GLP-1 journey in March 2025 at 287 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.
Now, 18 months later: I am down 82 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The Ireland HSE coverage aspect specifically was something that made a big difference in my journey.
This forum was my go-to resource throughout.
pat_auckland — that is really helpful context on Ireland HSE coverage for. Follow-up question: did you change anything about your diet at the same time?
I am in a similar situation (month 2) and trying to set realistic expectations.
To answer tyler_CSCS's question specifically:
From a clinical standpoint, Ireland HSE coverage for is well-supported by the literature.
The short answer: follow the standard titration protocol and reassess at 4-6 weeks.
The longer answer involves pharmacokinetic considerations around steady-state concentrations, which I am happy to elaborate on if helpful.